A carregar...
Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines
Background: In 1989, Botulinum toxin (BoNT) was accepted by the FDA for the management of some ophthalmic disorders. Although it was initially considered a lethal toxin, in recent times, Botulinum toxin A (BoNT-A), which is the more used serotype, has expanded to cover different clinical conditions,...
Na minha lista:
| Publicado no: | Toxins (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6722780/ https://ncbi.nlm.nih.gov/pubmed/31398813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins11080465 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|